Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Plasma Exchange | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Placental and Umbilical Cord Blood as a Source of Stem Cells | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Physiologic Insulin Resensitization (PIR) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Phrenic Nerve Stimulation for Central Sleep Apnea | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Phototherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Photodynamic Therapy for Choroidal Neovascularization | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Phlebotomy, Therapeutic | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pharmacogenomic and Metabolite Markers for Individuals Treated with Thiopurines | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pharmacogenetic Testing for Pain Management | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Gastroparesis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Peripheral Subcutaneous Field Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Peripheral Nerve Injury Repair Using Synthetic Conduits or Processed Nerve Allografts | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Revascularization Procedures for Lower Extremity Peripheral Arterial Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, Biacuplasty and Intraosseous Basivertebral Nerve Ablation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Electrical Nerve Stimulation, Percutaneous Neuromodulation Therapy, and Restorative Neurostimulation Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel Syndrome | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pediatric Dental Anesthesia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | PCSK9 Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Patient-Specific Instrumentation (eg, Cutting Guides) for Joint Arthroplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Patient-Controlled End Range of Motion Stretching Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pathogen Panel Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Parenteral (PEN) and Enteral (EN) Nutrition Support in the Home | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Parathyroid Autotransplantation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Paraspinal Surface Electromyography to Evaluate and Monitor Back Pain | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Papzimeos (zopapogene imadenovec-drba) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Palynziq (pegvaliase-pqpz) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pain Control Infusion Pump | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oxygen | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oxlumo (lumasiran) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Otoplasty, Unilateral or Bilateral | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Otezla (apremilast) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthoptic Training for the Treatment of Vision or Learning Disabilities | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used with Autologous Bone Marrow) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthopedic Applications of Platelet-Rich Plasma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthognathic Surgery (Overbite/Underbite) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Organic Acid Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oral Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oracea (doxycycline, biphasic release) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Coherence Tomography of the Anterior Eye Segment | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Coherence Tomography for Imaging of Coronary Arteries | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Opioid Antagonists under Heavy Sedation or General Anesthesia as a Technique of Opioid Detoxification | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Opioid and Opioid Combination Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ophthalmologic Techniques That Evaluate the Posterior Eye Segment for Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ophthalmic Anti-Inflammatory Medications | New policy |